The University of Chicago Header Logo

Connection

Anjana Pillai to Programmed Cell Death 1 Receptor

Back to Details
This is a "connection" page, showing publications Anjana Pillai has written about Programmed Cell Death 1 Receptor.
Anjana Pillai
Connection Strength
0.046
Programmed Cell Death 1 Receptor
  1. Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study. J Immunother Cancer. 2022 06; 10(6).
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.